No Data
No Data
華康生物醫學:2023年報
Huakang Biomedical (08622) completed placement of 31 million shares to raise approximately HK$2.96 million
Huakang Biomedical (08622) issued an announcement. The conditions for the placement have been met, and on April 2, 2024...
Huakang Biomedical (08622.HK) obtained Kokusai Resources Company Limited's additional common shares by 35.272 million shares worth approximately HK$4.317,300
On April 5, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 5, Kokusai Resources Company Limited increased its share holdings of $Huakang Biomedical (08622.HK) $35.272 million on March 26 with an average price of HK$0.1224 per share on the market and HK$0.121 per share outside the market, totaling HK$35.272 million, worth about HK$4.317,300. After the increase in holdings, Kokusai Resources Company Limited's latest shareholding number was 121 million shares, and the ratio of good positions was
Huakang Biomedical (08622.HK) received 12.728 million additional shares of common stock worth approximately HK$1,538,800 from Kokusai Resources Company Limited
On April 5, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 5, Kokusai Resources Company Limited increased its share holdings of $Huakang Biomedical (08622.HK) by $12.728 million at an average price of HK$0.1209 per share on March 25, worth approximately HK$1,538,800. After the increase in holdings, Kokusai Resources Company Limited's latest shareholding was 85.48 million shares, and the good position ratio rose from 16.59% to 18.21%. Honko
Huakang Biomedical (08622.HK): Chen Jiansheng Resigns as Independent Non-Executive Director
Huakang Biomedical (08622.HK) announced that Chen Jiansheng resigned as an independent non-executive director of the company, a member of the Audit Committee and Nomination Committee in order to invest more time in his personal business and other matters, effective April 2, 2024.
Huakang Biomedical (08622) announced 2023 results, net loss of 5.782 million yuan, an increase of 88% year-on-year
Huakang Biomedical (08622) announced its 2023 results, with revenue of 246.29 million yuan, a year-on-year decrease of 2.8...
No Data